Loading…
489 Interleukin Phenotype in Patients with Pfapa
Background PFAPA is a chronic condition including recurrent fever episodes, aphthous stomatitis, pharyngitis, adenitis. According to a previous study, even between febrile attacks, there is increasing of pro-inflammatory mediators. Aims To evaluate serum interleukin phenotype between febril episode...
Saved in:
Published in: | Archives of disease in childhood 2012-10, Vol.97 (Suppl 2), p.A143-A143 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | A143 |
container_issue | Suppl 2 |
container_start_page | A143 |
container_title | Archives of disease in childhood |
container_volume | 97 |
creator | Iurian, SI Dobrota, L Iurian, S Neamtu, ML Bera, L Rosenberg, A |
description | Background PFAPA is a chronic condition including recurrent fever episodes, aphthous stomatitis, pharyngitis, adenitis. According to a previous study, even between febrile attacks, there is increasing of pro-inflammatory mediators. Aims To evaluate serum interleukin phenotype between febril episode in PFAPA patients from our clinic; To establish correlation between C reactive protein (CRP) and pro-inflammatory interleukins: tumor necrosis factor-alpha (TNFα), interleukin-8 (IL-8); To evaluate link between CRP and anti-inflammatory interleukins: interleukin-10 (IL-10); To identify a sensitive biological marker to estimate PFAPA evolution. Methods Authors analyzed 2 groups: “PFAPA group” represented by 6 patients and “control group” containing 4 no-PFAPA patients. Inclusion citeria: patients up to 10 years of age that fulfilled PFAPA diagnosis criteria; patients between febrile attacks; negative procalcitonin (PCT) blood value in order to exclude bacterial infections for study patients. Exclusion criteria: patients during febrile attacks. Both groups patients were tested for serum levels of PCT, CRP, IL-8, TNFα, IL-10. Data was statistically analyzed using independent “t” test. Results Both group patients have normal serum levels for interleukins 8/10 and high TNFα values. Mean value for TNFα was 11.26 pg/ml in PFAPA group and 13.2 pg/ml in no-PFAPA group. Regarding CRP values, mean value for PFAPA patients was 19.72 (range between 2.4–95) as compare to 5.04 in no-PFAPA patients. Conclusions TNFα, IL-8, IL-10 aren’t useful to appreciate PFAPA evolution pattern. CRP remains a sensitive marker for disease activity in PFAPA patients, even out of fever attacks. Our study didn’t confirm previous study data. |
doi_str_mv | 10.1136/archdischild-2012-302724.0489 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1828862498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4214782791</sourcerecordid><originalsourceid>FETCH-LOGICAL-b2249-ffef8b0e84388700fd3e2b35faf34d1f7e2d196f5ae3deb9997affe46de204333</originalsourceid><addsrcrecordid>eNqVkMtOwzAQRS0EEqXwD5EQS4NfTZwFC4h4FAp0AWwtpx4r6SMJtivo3-MoCLFlNZrRuXNnLkJnlJxTytML7RaVqf2iqtcGM0IZ5oRlTJwTIfM9NKIilXEuxD4aEUI4zqWUh-jI-yWJtJR8hHo0mTYB3Bq2q7pJ5hU0bdh1kPSNDjU0wSefdaiSudWdPkYHVq89nPzUMXq7vXkt7vHs5W5aXM1wyZjIsbVgZUlACi5lRog1HFjJJ1ZbLgy1GTBD89RONHADZZ7nmY4akRqIF3POx-h02Nu59mMLPqhlu3VNtFRUxtvT6CIjdTlQC9d678CqztUb7XaKEtWHpP6GpPqQ1BCS6j-Pejzoax_g61es3UqlGc8m6vm9UOzxejZ_KJ4Ui7wc-HKz_KfVN9wSfvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1828862498</pqid></control><display><type>article</type><title>489 Interleukin Phenotype in Patients with Pfapa</title><source>Social Science Premium Collection</source><source>Education Collection</source><creator>Iurian, SI ; Dobrota, L ; Iurian, S ; Neamtu, ML ; Bera, L ; Rosenberg, A</creator><creatorcontrib>Iurian, SI ; Dobrota, L ; Iurian, S ; Neamtu, ML ; Bera, L ; Rosenberg, A</creatorcontrib><description>Background PFAPA is a chronic condition including recurrent fever episodes, aphthous stomatitis, pharyngitis, adenitis. According to a previous study, even between febrile attacks, there is increasing of pro-inflammatory mediators. Aims To evaluate serum interleukin phenotype between febril episode in PFAPA patients from our clinic; To establish correlation between C reactive protein (CRP) and pro-inflammatory interleukins: tumor necrosis factor-alpha (TNFα), interleukin-8 (IL-8); To evaluate link between CRP and anti-inflammatory interleukins: interleukin-10 (IL-10); To identify a sensitive biological marker to estimate PFAPA evolution. Methods Authors analyzed 2 groups: “PFAPA group” represented by 6 patients and “control group” containing 4 no-PFAPA patients. Inclusion citeria: patients up to 10 years of age that fulfilled PFAPA diagnosis criteria; patients between febrile attacks; negative procalcitonin (PCT) blood value in order to exclude bacterial infections for study patients. Exclusion criteria: patients during febrile attacks. Both groups patients were tested for serum levels of PCT, CRP, IL-8, TNFα, IL-10. Data was statistically analyzed using independent “t” test. Results Both group patients have normal serum levels for interleukins 8/10 and high TNFα values. Mean value for TNFα was 11.26 pg/ml in PFAPA group and 13.2 pg/ml in no-PFAPA group. Regarding CRP values, mean value for PFAPA patients was 19.72 (range between 2.4–95) as compare to 5.04 in no-PFAPA patients. Conclusions TNFα, IL-8, IL-10 aren’t useful to appreciate PFAPA evolution pattern. CRP remains a sensitive marker for disease activity in PFAPA patients, even out of fever attacks. Our study didn’t confirm previous study data.</description><identifier>ISSN: 0003-9888</identifier><identifier>EISSN: 1468-2044</identifier><identifier>DOI: 10.1136/archdischild-2012-302724.0489</identifier><identifier>CODEN: ADCHAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</publisher><subject>Bacterial diseases ; Control Groups ; Patients</subject><ispartof>Archives of disease in childhood, 2012-10, Vol.97 (Suppl 2), p.A143-A143</ispartof><rights>2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><rights>Copyright: 2012 (c) 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1828862498/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1828862498?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21377,21393,27923,27924,33610,33876,43732,43879,74092,74268</link.rule.ids></links><search><creatorcontrib>Iurian, SI</creatorcontrib><creatorcontrib>Dobrota, L</creatorcontrib><creatorcontrib>Iurian, S</creatorcontrib><creatorcontrib>Neamtu, ML</creatorcontrib><creatorcontrib>Bera, L</creatorcontrib><creatorcontrib>Rosenberg, A</creatorcontrib><title>489 Interleukin Phenotype in Patients with Pfapa</title><title>Archives of disease in childhood</title><addtitle>Arch Dis Child</addtitle><description>Background PFAPA is a chronic condition including recurrent fever episodes, aphthous stomatitis, pharyngitis, adenitis. According to a previous study, even between febrile attacks, there is increasing of pro-inflammatory mediators. Aims To evaluate serum interleukin phenotype between febril episode in PFAPA patients from our clinic; To establish correlation between C reactive protein (CRP) and pro-inflammatory interleukins: tumor necrosis factor-alpha (TNFα), interleukin-8 (IL-8); To evaluate link between CRP and anti-inflammatory interleukins: interleukin-10 (IL-10); To identify a sensitive biological marker to estimate PFAPA evolution. Methods Authors analyzed 2 groups: “PFAPA group” represented by 6 patients and “control group” containing 4 no-PFAPA patients. Inclusion citeria: patients up to 10 years of age that fulfilled PFAPA diagnosis criteria; patients between febrile attacks; negative procalcitonin (PCT) blood value in order to exclude bacterial infections for study patients. Exclusion criteria: patients during febrile attacks. Both groups patients were tested for serum levels of PCT, CRP, IL-8, TNFα, IL-10. Data was statistically analyzed using independent “t” test. Results Both group patients have normal serum levels for interleukins 8/10 and high TNFα values. Mean value for TNFα was 11.26 pg/ml in PFAPA group and 13.2 pg/ml in no-PFAPA group. Regarding CRP values, mean value for PFAPA patients was 19.72 (range between 2.4–95) as compare to 5.04 in no-PFAPA patients. Conclusions TNFα, IL-8, IL-10 aren’t useful to appreciate PFAPA evolution pattern. CRP remains a sensitive marker for disease activity in PFAPA patients, even out of fever attacks. Our study didn’t confirm previous study data.</description><subject>Bacterial diseases</subject><subject>Control Groups</subject><subject>Patients</subject><issn>0003-9888</issn><issn>1468-2044</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>ALSLI</sourceid><sourceid>CJNVE</sourceid><sourceid>M0P</sourceid><recordid>eNqVkMtOwzAQRS0EEqXwD5EQS4NfTZwFC4h4FAp0AWwtpx4r6SMJtivo3-MoCLFlNZrRuXNnLkJnlJxTytML7RaVqf2iqtcGM0IZ5oRlTJwTIfM9NKIilXEuxD4aEUI4zqWUh-jI-yWJtJR8hHo0mTYB3Bq2q7pJ5hU0bdh1kPSNDjU0wSefdaiSudWdPkYHVq89nPzUMXq7vXkt7vHs5W5aXM1wyZjIsbVgZUlACi5lRog1HFjJJ1ZbLgy1GTBD89RONHADZZ7nmY4akRqIF3POx-h02Nu59mMLPqhlu3VNtFRUxtvT6CIjdTlQC9d678CqztUb7XaKEtWHpP6GpPqQ1BCS6j-Pejzoax_g61es3UqlGc8m6vm9UOzxejZ_KJ4Ui7wc-HKz_KfVN9wSfvA</recordid><startdate>201210</startdate><enddate>201210</enddate><creator>Iurian, SI</creator><creator>Dobrota, L</creator><creator>Iurian, S</creator><creator>Neamtu, ML</creator><creator>Bera, L</creator><creator>Rosenberg, A</creator><general>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88B</scope><scope>88E</scope><scope>88I</scope><scope>8A4</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>CJNVE</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0P</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEDU</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope></search><sort><creationdate>201210</creationdate><title>489 Interleukin Phenotype in Patients with Pfapa</title><author>Iurian, SI ; Dobrota, L ; Iurian, S ; Neamtu, ML ; Bera, L ; Rosenberg, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b2249-ffef8b0e84388700fd3e2b35faf34d1f7e2d196f5ae3deb9997affe46de204333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Bacterial diseases</topic><topic>Control Groups</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iurian, SI</creatorcontrib><creatorcontrib>Dobrota, L</creatorcontrib><creatorcontrib>Iurian, S</creatorcontrib><creatorcontrib>Neamtu, ML</creatorcontrib><creatorcontrib>Bera, L</creatorcontrib><creatorcontrib>Rosenberg, A</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Education Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Education Periodicals</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Education Collection</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Education Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Education</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Archives of disease in childhood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iurian, SI</au><au>Dobrota, L</au><au>Iurian, S</au><au>Neamtu, ML</au><au>Bera, L</au><au>Rosenberg, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>489 Interleukin Phenotype in Patients with Pfapa</atitle><jtitle>Archives of disease in childhood</jtitle><addtitle>Arch Dis Child</addtitle><date>2012-10</date><risdate>2012</risdate><volume>97</volume><issue>Suppl 2</issue><spage>A143</spage><epage>A143</epage><pages>A143-A143</pages><issn>0003-9888</issn><eissn>1468-2044</eissn><coden>ADCHAK</coden><abstract>Background PFAPA is a chronic condition including recurrent fever episodes, aphthous stomatitis, pharyngitis, adenitis. According to a previous study, even between febrile attacks, there is increasing of pro-inflammatory mediators. Aims To evaluate serum interleukin phenotype between febril episode in PFAPA patients from our clinic; To establish correlation between C reactive protein (CRP) and pro-inflammatory interleukins: tumor necrosis factor-alpha (TNFα), interleukin-8 (IL-8); To evaluate link between CRP and anti-inflammatory interleukins: interleukin-10 (IL-10); To identify a sensitive biological marker to estimate PFAPA evolution. Methods Authors analyzed 2 groups: “PFAPA group” represented by 6 patients and “control group” containing 4 no-PFAPA patients. Inclusion citeria: patients up to 10 years of age that fulfilled PFAPA diagnosis criteria; patients between febrile attacks; negative procalcitonin (PCT) blood value in order to exclude bacterial infections for study patients. Exclusion criteria: patients during febrile attacks. Both groups patients were tested for serum levels of PCT, CRP, IL-8, TNFα, IL-10. Data was statistically analyzed using independent “t” test. Results Both group patients have normal serum levels for interleukins 8/10 and high TNFα values. Mean value for TNFα was 11.26 pg/ml in PFAPA group and 13.2 pg/ml in no-PFAPA group. Regarding CRP values, mean value for PFAPA patients was 19.72 (range between 2.4–95) as compare to 5.04 in no-PFAPA patients. Conclusions TNFα, IL-8, IL-10 aren’t useful to appreciate PFAPA evolution pattern. CRP remains a sensitive marker for disease activity in PFAPA patients, even out of fever attacks. Our study didn’t confirm previous study data.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health</pub><doi>10.1136/archdischild-2012-302724.0489</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-9888 |
ispartof | Archives of disease in childhood, 2012-10, Vol.97 (Suppl 2), p.A143-A143 |
issn | 0003-9888 1468-2044 |
language | eng |
recordid | cdi_proquest_journals_1828862498 |
source | Social Science Premium Collection; Education Collection |
subjects | Bacterial diseases Control Groups Patients |
title | 489 Interleukin Phenotype in Patients with Pfapa |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A38%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=489%20Interleukin%20Phenotype%20in%20Patients%20with%20Pfapa&rft.jtitle=Archives%20of%20disease%20in%20childhood&rft.au=Iurian,%20SI&rft.date=2012-10&rft.volume=97&rft.issue=Suppl%202&rft.spage=A143&rft.epage=A143&rft.pages=A143-A143&rft.issn=0003-9888&rft.eissn=1468-2044&rft.coden=ADCHAK&rft_id=info:doi/10.1136/archdischild-2012-302724.0489&rft_dat=%3Cproquest_cross%3E4214782791%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b2249-ffef8b0e84388700fd3e2b35faf34d1f7e2d196f5ae3deb9997affe46de204333%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1828862498&rft_id=info:pmid/&rfr_iscdi=true |